HK219196A - Use of sertraline for the treatment of premature ejaculation - Google Patents

Use of sertraline for the treatment of premature ejaculation

Info

Publication number
HK219196A
HK219196A HK219196A HK219196A HK219196A HK 219196 A HK219196 A HK 219196A HK 219196 A HK219196 A HK 219196A HK 219196 A HK219196 A HK 219196A HK 219196 A HK219196 A HK 219196A
Authority
HK
Hong Kong
Prior art keywords
sertraline
treatment
premature ejaculation
ejaculation
naphthal
Prior art date
Application number
HK219196A
Other languages
English (en)
Inventor
Peter A Bick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23583530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK219196(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of HK219196A publication Critical patent/HK219196A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK219196A 1989-08-30 1996-12-24 Use of sertraline for the treatment of premature ejaculation HK219196A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/400,417 US4940731A (en) 1989-08-30 1989-08-30 Method of treating premature ejaculation using sertraline

Publications (1)

Publication Number Publication Date
HK219196A true HK219196A (en) 1997-01-03

Family

ID=23583530

Family Applications (1)

Application Number Title Priority Date Filing Date
HK219196A HK219196A (en) 1989-08-30 1996-12-24 Use of sertraline for the treatment of premature ejaculation

Country Status (19)

Country Link
US (1) US4940731A (de)
EP (1) EP0415613B1 (de)
JP (1) JPH0393718A (de)
KR (1) KR910004187A (de)
AT (1) ATE110958T1 (de)
AU (1) AU609664B1 (de)
CA (1) CA2024188C (de)
CY (1) CY1973A (de)
DE (1) DE69012261T2 (de)
DK (1) DK0415613T3 (de)
HK (1) HK219196A (de)
HU (1) HU213474B (de)
IE (1) IE63470B1 (de)
IL (1) IL95473A (de)
MY (1) MY106938A (de)
NZ (1) NZ235101A (de)
PH (1) PH26998A (de)
PT (1) PT95117B (de)
ZA (1) ZA906883B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148511B1 (ko) * 1993-09-14 1998-11-02 최형기 성신경과민증 예방 및 치료용 의약조성물
US5597826A (en) * 1994-09-14 1997-01-28 Pfizer Inc. Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
EP0999830A1 (de) 1997-07-01 2000-05-17 Pfizer Inc. Sertraline salze und dozierungsformen für dauerverabreichung enthaltend sertraline
US20030133974A1 (en) * 1997-07-01 2003-07-17 Curatolo William John Encapsulated solution dosage forms of sertraline
US20040208926A1 (en) * 1997-07-01 2004-10-21 Pfizer Inc Solubilized sertraline compositions
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
US6037360A (en) * 1997-10-28 2000-03-14 Vivus, Incorporated Administration of 5-HT3 receptor antagonists to treat premature ejaculation
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6228864B1 (en) 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
CA2346335C (en) * 1998-10-13 2006-04-18 Pfizer Products Inc. Sertraline oral concentrate
IL132500A0 (en) 1998-10-29 2001-03-19 Pfizer Prod Inc Stereoselective microbial reduction of a racemic tetralone
AU2315400A (en) * 1999-03-01 2000-09-21 Middleton, Donald Stuart 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
US6245782B1 (en) 1999-05-17 2001-06-12 Heartdrug Research L.L.C. Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
ES2393582T3 (es) 1999-09-03 2012-12-26 Apbi Holdings, Llc Procedimiento de utilización de inhibidores de la recaptación de serotonina selectivos de inicio rápido de acción para el tratamiento de las disfunciones sexuales
JP2003518487A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク ヒドロゲル駆動型積層薬物製剤
GB0007884D0 (en) * 2000-03-31 2000-05-17 Pfizer Ltd Diphenyl ether compounds useful in therapy
US6448293B1 (en) 2000-03-31 2002-09-10 Pfizer Inc. Diphenyl ether compounds useful in therapy
CN1091096C (zh) * 2000-09-15 2002-09-18 哈尔滨健迪医药科技开发有限公司 舍曲林柠檬酸盐及其用于治疗哺乳动物早泄的用途
US6495154B1 (en) 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
US6974839B2 (en) 2001-03-16 2005-12-13 Dmi Biosciences, Inc. Method of delaying ejaculation
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
EP1737473A4 (de) * 2004-04-19 2009-08-26 Noven Therapeutics Llc Lithium-kombinationen und relevante verwendungen
BRPI0509592A (pt) * 2004-05-06 2007-09-25 Cydex Inc formulações de sabor mascarado, contendo sertralina e ciclodextrina de éter de sulfoalquila
JP5528705B2 (ja) * 2005-12-13 2014-06-25 トリニティ ラボラトリーズ インコーポレイテッド ヒトにおける早漏を治療するための方法
US7893053B2 (en) 2006-06-16 2011-02-22 Theracos, Inc. Treating psychological conditions using muscarinic receptor M1 antagonists
US20090005319A1 (en) * 2007-07-01 2009-01-01 Barone Jr Frank V Topical compositions for delaying ejaculation and methods of using the same
US9272671B2 (en) 2013-06-28 2016-03-01 Faurecia Interior Systems, Inc. Display screen arrangement and method of assembly

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029731A (en) * 1974-11-06 1977-06-14 Pfizer Inc. Aminophenyltetralin compounds
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4507323A (en) * 1984-07-25 1985-03-26 Burroughs Wellcome Co. Treatment of psychosexual dysfunctions
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline

Also Published As

Publication number Publication date
IE63470B1 (en) 1995-04-19
EP0415613B1 (de) 1994-09-07
PH26998A (en) 1993-02-01
KR910004187A (ko) 1991-03-28
DE69012261D1 (de) 1994-10-13
EP0415613A2 (de) 1991-03-06
HU213474B (en) 1997-06-30
NZ235101A (en) 1997-01-29
ATE110958T1 (de) 1994-09-15
CA2024188A1 (en) 1991-03-01
PT95117B (pt) 1997-05-28
EP0415613A3 (en) 1992-02-26
MY106938A (en) 1995-08-30
DK0415613T3 (da) 1994-10-10
DE69012261T2 (de) 1995-01-12
HUT58512A (en) 1992-03-30
CA2024188C (en) 1994-11-08
AU609664B1 (en) 1991-05-02
ZA906883B (en) 1992-04-29
JPH0393718A (ja) 1991-04-18
US4940731A (en) 1990-07-10
IL95473A (en) 1995-08-31
CY1973A (en) 1997-09-05
IE903123A1 (en) 1991-03-13
HU905682D0 (en) 1991-03-28
PT95117A (pt) 1991-05-22

Similar Documents

Publication Publication Date Title
CY1973A (en) Use of sertraline for the treatment of premature ejaculation
MY106075A (en) A method of treating anxiety-related disorders using sertraline.
HK1004257A1 (en) Use of droloxifene in the treatment of bone diseases
CA2061270A1 (en) Method and Composition for Treating Reperfusion Injury
EP0911331A3 (de) Substutierte Dibenzoxazepinverbindungen, pharmazeutische Zusammensetzungen, und Anwendungsmethoden
DE69521536T2 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
IL118833A0 (en) The use of sertraline to treat post myocardial infarction patients
HU905683D0 (en) The treatment of drug dependence by using sertraline
CA2167257A1 (en) Use of Sertraline to Treat Cancer Patients
NZ268110A (en) Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage
BG105434A (en) Sertraline oral concentrate
MX9602793A (es) Uso de sertralina para tratar pacientes despues de un infarto de miocardio.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)